United Kingdom Pharmaceuticals & Healthcare Report Q4 2012 - New Market Report Now Available
BMI View: We retain our broadly pessimistic outlook for the UK's pharmaceutical market over the five years to 2016, although the emphasis on cost containment will serve to boost the performance of the generic drug sector. A difficult economic situation will also prioritise economically priced items in the over-the-counter (OTC) arena, thus boosting the sale of 'private label' painkillers and similar medicines available for sale through non-pharmacy channels. In the meantime, the government will push ahead with its controversial National...
View full press release